Lithium treatment of meniere's disease. Results of a double-blind cross-over trial. 1976

J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff

21 patients with Meniere's disease participated in a double-blind, cross-over trial, with 6 months' lithium treatment and 6 months' placebo treatment. Even if the results were not completely unequivocal, no difference was found between lithium and placebo treatment. The results might imply that both other medical as well as surgical treatment of Meniere's disease exert a pure placebo effect; so far no controlled investigation has been published, establishing the value of surgical treatment of Meniere's disease.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008575 Meniere Disease A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops. Meniere's Disease,Meniere's Syndrome,Vertigo, Aural,Auditory Vertigo,Aural Vertigo,Ménière Disease,Ménière's Disease,Ménière's Vertigo,Otogenic Vertigo,Auditory Vertigos,Disease, Meniere,Disease, Meniere's,Disease, Ménière,Disease, Ménière's,Diseases, Ménière,Diseases, Ménière's,Meniere Syndrome,Menieres Disease,Menieres Syndrome,Ménière Diseases,Ménière Vertigo,Ménière's Diseases,Ménière's Vertigos,Ménières Disease,Ménières Vertigo,Otogenic Vertigos,Syndrome, Meniere's,Vertigo, Auditory,Vertigo, Ménière's,Vertigo, Otogenic,Vertigos, Auditory,Vertigos, Ménière's,Vertigos, Otogenic
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
May 1996, Progress in neuro-psychopharmacology & biological psychiatry,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
January 1978, Scandinavian journal of gastroenterology,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
December 1978, European journal of clinical pharmacology,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
August 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
October 1982, Clinical otolaryngology and allied sciences,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
May 1972, Paraplegia,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
July 1971, American heart journal,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
October 1984, Epilepsia,
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
April 1997, Multiple sclerosis (Houndmills, Basingstoke, England),
J Thomsen, and P Bech, and A Geisler, and S Prytz, and O J Rafaelsen, and P Vendsborg, and K Zilstorff
September 1983, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!